ENTEROMEDICS INC (ETRM)

Overview Price 2.22 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 4 - SELL Open Price $0.00 Previous Close $2.22 Daily Range $0.00 - $0.00 52-Week Range $1.52 - $3.29 Volume 0 EnteroMedics Inc. was established to develop and commercialize a new therapeutic platform for treating a wide range of acute and chronic diseases that are mediated by the vagal nerves. Due to the large unmet need for more effective surgical management of obesity, and following an in-depth analysis of how the vagus nerve affects food intake and processing, EnteroMedics has selected obesity management as its primary focus. Other Resources for ETRM Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary No Commentary Found for This Ticker. EnteroMedics Inc. was established to develop and commercialize a new therapeutic platform for treating a wide range of acute and chronic diseases that are mediated by the vagal nerves. Due to the large unmet need for more effective surgical management of obesity, and following an in-depth analysis of how the vagus nerve affects food intake and processing, EnteroMedics has selected obesity management as its primary focus.   Brokerage Analyst Recommendations 2 Brokerage Firms Covering ETRM   Strong Buy 2 Buy 0 Hold 0 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1   ETRM Ratings: BUY  SELL  HOLD ETRM Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 0 Buy 0 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
uwpltre	99.21	03/26/10	RW Evolution in progress	1	03/27/10

Commentary

There are no open picks with this stock at the moment.

Picks

There are no open picks with this stock at the moment.